BioSpace News Archive

The Autism Science Foundation, a nonprofit organization dedicated to funding innovative autism research and supporting families facing autism, announced the recipients of the newly renamed Suzanne Wright Memorial Research Accelerator Grants.

The gene synthesis market has been estimated to experience various growth opportunities in the forthcoming years.

GNS, the leader in the use of “Digital Twins” and Causal AI & biosimulation technology for biopharmaceutical drug discovery and development, and Servier, a global pharmaceutical group, today announced a collaboration to advance drug discovery, translational, and clinical development efforts in Multiple Myeloma (MM).

Nine organizations are joining forces to present the second annual ILD Day on Wednesday, Sept. 14, to drive awareness of interstitial lung disease (ILD).

Technological Innovations Leading To An Increase In Number Of New Product Launches Will Stimulate The Vascular Closure Device Market Expansion

BioAge Labs, Inc., a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, announced that it has initiated a partnership agreement with Age Labs AS, a diagnostic company that develops tests for the early detection of age-related diseases.

Roche announced CE label expansion of the VENTANA PD-L1 Assay in non-small cell lung cancer as a companion diagnostic for Tecentriq®.

RELIEF THERAPEUTICS Holding SA, announced today that it has filed a Registration Statement on Form F-1 under the Securities Act of 1933 with the U.S. Securities and Exchange Commission relating to a proposed offering of its ordinary shares in the form of American Depositary Shares.

Occlutech Holding AG is a leading specialist provider of minimally invasive structural heart implants.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, continues its preparation for commercialization with appointments of Matthew Casbon, Vice President of Sales, Marketing and Training, and Matthew Rysavy, Vice President of Market Access and Trade.